Faron Pharmaceuticals Oy (HEL:FARON)
2.440
+0.010 (0.41%)
At close: Apr 23, 2025
Faron Pharmaceuticals Oy Statistics
Total Valuation
HEL:FARON has a market cap or net worth of EUR 305.80 million. The enterprise value is 308.32 million.
Market Cap | 305.80M |
Enterprise Value | 308.32M |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
Earnings Date | Aug 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +36.07% |
Shares Change (QoQ) | +51.29% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 91.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -31.33 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -11.90 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.09
Current Ratio | 1.09 |
Quick Ratio | 0.96 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.73 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -102.64% |
Return on Invested Capital (ROIC) | -7,728.89% |
Return on Capital Employed (ROCE) | -794.60% |
Revenue Per Employee | n/a |
Profits Per Employee | -1.04M |
Employee Count | 25 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +73.57% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +73.57% |
50-Day Moving Average | 2.30 |
200-Day Moving Average | 2.20 |
Relative Strength Index (RSI) | 48.73 |
Average Volume (20 Days) | 616,232 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -18.67M |
Pretax Income | -25.92M |
Net Income | -25.92M |
EBITDA | -18.47M |
EBIT | -18.67M |
Earnings Per Share (EPS) | -0.29 |
Balance Sheet
The company has 9.50 million in cash and 12.11 million in debt, giving a net cash position of -2.61 million.
Cash & Cash Equivalents | 9.50M |
Total Debt | 12.11M |
Net Cash | -2.61M |
Net Cash Per Share | n/a |
Equity (Book Value) | -9.76M |
Book Value Per Share | -0.09 |
Working Capital | 894,000 |
Cash Flow
Operating Cash Flow | -22.97M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
HEL:FARON does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -36.07% |
Shareholder Yield | -36.07% |
Earnings Yield | -8.48% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |